FIELD: medicine, pharmacy. SUBSTANCE: pharmaceutical composition has 9-cis-retinoic acid and pharmaceutically acceptable carrier. Composition is used for treatment of patients with epithelial damages or tumors, skin radiation damages, psoriasis, mouth cavity leukoplakia and for decrease of fat secretion. The proposed composition shows a limited toxicity and other negative effects caused by retinoids. EFFECT: enhanced effectiveness of composition. 7 cl, 7 ex
Authors
Dates
1998-09-27—Published
1993-01-20—Filed